Skip to main content
Literatur
2.
Zurück zum Zitat Hofman MA, Swaab DF (1992) The human hypothalamus: comparative morphometry and photoperiodic influences. Prog Brain Res 93:133–147CrossRef Hofman MA, Swaab DF (1992) The human hypothalamus: comparative morphometry and photoperiodic influences. Prog Brain Res 93:133–147CrossRef
3.
Zurück zum Zitat Hofman MA, Swaab DF (1993) Diurnal and seasonal rhythms of neuronal activity in the suprachiasmatic nucleus of humans. J Biol Rhythms 8:283–295CrossRef Hofman MA, Swaab DF (1993) Diurnal and seasonal rhythms of neuronal activity in the suprachiasmatic nucleus of humans. J Biol Rhythms 8:283–295CrossRef
4.
Zurück zum Zitat Bernstein HG, Heinemann A, Krell D, Dobrowolny H, Bielau H, Keilhoff G, Bogerts B (2005) Hypothalamic nitric oxide synthase in affective disorder: focus on the suprachiasmatic nucleus. Cell Mol Biol (Noisy-le-grand) 51:279–284 Bernstein HG, Heinemann A, Krell D, Dobrowolny H, Bielau H, Keilhoff G, Bogerts B (2005) Hypothalamic nitric oxide synthase in affective disorder: focus on the suprachiasmatic nucleus. Cell Mol Biol (Noisy-le-grand) 51:279–284
5.
Zurück zum Zitat Zhou JN, Riemersma RF, Unmehopa UA, Hoogendijk WJ, van Heerikhuize JJ, Hofman MA, Swaab DF (2001) Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression. Arch Gen Psychiatry 58:655–662CrossRef Zhou JN, Riemersma RF, Unmehopa UA, Hoogendijk WJ, van Heerikhuize JJ, Hofman MA, Swaab DF (2001) Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression. Arch Gen Psychiatry 58:655–662CrossRef
6.
Zurück zum Zitat Bernstein HG, Heinemann A, Krell D, Mawrin C, Bielau H, Danos P, Diekmann S, Keilhoff G, Bogerts B, Baumann B (2002) Further immunohistochemical evidence for impaired NO signaling in the hypothalamus of depressed patients. Ann N Y Acad Sci 973:91–93CrossRef Bernstein HG, Heinemann A, Krell D, Mawrin C, Bielau H, Danos P, Diekmann S, Keilhoff G, Bogerts B, Baumann B (2002) Further immunohistochemical evidence for impaired NO signaling in the hypothalamus of depressed patients. Ann N Y Acad Sci 973:91–93CrossRef
8.
Zurück zum Zitat Bernstein HG, Keilhoff G, Steiner J, Dobrowolny H, Bogerts B (2011) Nitric oxide and schizophrenia: present knowledge and emerging concepts of therapy. CNS Neurol Disord Drug Targets 10:792–807CrossRef Bernstein HG, Keilhoff G, Steiner J, Dobrowolny H, Bogerts B (2011) Nitric oxide and schizophrenia: present knowledge and emerging concepts of therapy. CNS Neurol Disord Drug Targets 10:792–807CrossRef
10.
Zurück zum Zitat Kudlow P, Cha DS, Carvalho AF, McIntyre RS (2016) Nitric oxide and major depressive disorder: pathophysiology and treatment implications. Curr Mol Med 16:206–215CrossRef Kudlow P, Cha DS, Carvalho AF, McIntyre RS (2016) Nitric oxide and major depressive disorder: pathophysiology and treatment implications. Curr Mol Med 16:206–215CrossRef
13.
Zurück zum Zitat Bernstein HG, Bogerts B, Keilhoff G (2005) The many faces of nitric oxide in schizophrenia. A review. Schizophr Res 78:69–86CrossRef Bernstein HG, Bogerts B, Keilhoff G (2005) The many faces of nitric oxide in schizophrenia. A review. Schizophr Res 78:69–86CrossRef
Metadaten
Titel
Postmortem studies indicate altered cell chemical composition of the suprachiasmatic nucleus in mood disorders
verfasst von
Hans-Gert Bernstein
Bernhard Bogerts
Gerburg Keilhoff
Johann Steiner
Publikationsdatum
08.11.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 8/2018
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-017-0849-z

Weitere Artikel der Ausgabe 8/2018

European Archives of Psychiatry and Clinical Neuroscience 8/2018 Zur Ausgabe

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.